Eltrombopag for the treatment of immune thrombocytopenia.
about
Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopeniaRomiplostim therapy in children with unresponsive chronic immune thrombocytopenia.A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopeniaHematopoietic, CNS and skeletal muscle stem cells as drug targets: opportunities, progress and challenges.Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.
P2860
Eltrombopag for the treatment of immune thrombocytopenia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Eltrombopag for the treatment of immune thrombocytopenia.
@ast
Eltrombopag for the treatment of immune thrombocytopenia.
@en
type
label
Eltrombopag for the treatment of immune thrombocytopenia.
@ast
Eltrombopag for the treatment of immune thrombocytopenia.
@en
prefLabel
Eltrombopag for the treatment of immune thrombocytopenia.
@ast
Eltrombopag for the treatment of immune thrombocytopenia.
@en
P2860
P356
P1476
Eltrombopag for the treatment of immune thrombocytopenia.
@en
P2093
Gregory Cheng
P2860
P304
P356
10.1586/EHM.11.25
P577
2011-06-01T00:00:00Z